Streetbeat News

Products Services

HAO

Haoxi Health Technology Limited (HAO), a Beijing-based online marketing solution provider, announced a rebate agreement with Jinan Yanling Biotechnology Co., Ltd. and its affiliates for advertising services. The agreement involves a minimum spend of $7 million on ByteDance's platforms, including Jinri Toutiao, Douyin, and Xigua Video, to enhance Yanling's exposure and market reach. This partnership aims to leverage ByteDance's extensive user base for targeted advertising, offering rebates based on various performance metrics.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:02 pm

CMND

Clearmind (CMND) has secured exclusive global rights to develop, manufacture, and commercialize innovative compounds invented by Professors Rami Yaka, Ahmed Masaewa, and Avi Priel from The Hebrew University.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:48 am

CMND

Clearmind Medicine has entered into an exclusive patent licensing agreement with Yissum Research Development Company. This agreement grants Clearmind exclusive rights to develop, manufacture, and commercialize novel compounds aimed at treating PTSD and other mental health disorders.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:47 am

BYDDF

BYDDY

NIO

Nio has partnered with BYD, backed by Warren Buffett, to launch a budget-friendly EV brand named 'Onvo', aiming to compete with Tesla's Model Y. This partnership allows Nio to source batteries from BYD, alongside its current supplier CATL, and another provider CALB for different versions of the Onvo EV. This move is part of a broader strategy to reduce costs and compete more effectively in the fiercely competitive Chinese EV market. BYD, having surpassed Tesla in global EV production, is focusing on making EVs more affordable than gasoline vehicles.

Portfolio Pulse from Benzinga Neuro

May 07, 2024 | 11:44 am

AGEN

Agenus is set to release updated Phase 1 and 2 data later this year for its ongoing studies in melanoma, lung cancer, sarcoma, and pancreatic cancer. This announcement indicates significant progress in the company's oncology research and development efforts.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:41 am

IVVD

Invivyd announced plans to pursue a rapid immunobridging pathway for potential Emergency Use Authorization (EUA) for its COVID-19 treatment, targeting moderately to severely immunocompromised individuals, following feedback from the U.S. FDA.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:39 am

BTCUSD

ETHUSD

Prominent crypto analyst Capo Of Crypto predicts Ethereum (ETH) will outperform Bitcoin (BTC) in the coming days, citing a strong bounce from the support zone and potential bullish continuation for ETH. The analysis also highlights the strength of the ETH/BTC pair and anticipates Ethereum ETFs' approval as a significant upcoming event that could further boost ETH's performance. However, skepticism exists regarding the timeline for Ethereum ETF approval, with some analysts suggesting a delay until 2025.

Portfolio Pulse from Khyathi Dalal

May 07, 2024 | 11:37 am

LDTC

LeddarTech and Immervision have announced a collaboration to expedite the training of perception models for Advanced Driver Assistance Systems (ADAS) and Autonomous Driving (AD). This partnership aims to enhance the development and efficiency of ADAS and AD technologies.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:34 am

BA

SPR

Spirit Aerosystems has announced it will not provide guidance until there is further clarity on several key issues, including its acquisition discussions with Boeing, the timing of 737 MAX deliveries and production, and its ongoing commercial negotiations with Airbus.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:34 am

ITCI

Intra-cellular Therapies has reaffirmed its full-year 2024 net product sales guidance for Caplyta, projecting revenues between $645 million and $675 million. This reiteration underscores the company's confidence in Caplyta's market performance and future sales prospects.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:33 am